Article
Washington - A glycoprotein vaccine has induced significant protection against genital herpes disease in women with no evidence of either herpes simplex virus 1 or HSV 2 infection, said Stephen K. Tyring, M.D., Ph.D., at the annual meeting of the American Academy of Dermatology.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
2 Commerce Drive
Cranbury, NJ 08512